T Stamp lines up at-the-market sale facility up to $5.32 million (NASDAQ: IDAI)

What happened

T Stamp Inc. (NASDAQ: IDAI) agreed to an at-the-market stock sale facility capped at $5.32 million on October 9, 2026. The company entered a distribution agreement with Maxim Group LLC. Maxim will use commercially reasonable efforts to sell shares from time to time.

It may act as sales agent or principal based on T Stamp's instructions. T Stamp can set minimum price, time or size limits for sales. The filing says sales may be made by any method deemed at-the-market under Rule 415 or by any other method permitted by law, including privately negotiated transactions. The shares are authorized but unissued common stock. T Stamp will pay a 3.0% commission on the aggregate gross proceeds from each sale.

T Stamp also agreed to reimburse Maxim for up to $40,000 of specified expenses and up to $3,000 quarterly for counsel fees and incidental expenses. The company says it is not required to make any sales under the agreement. The arrangement may also end by mutual termination on 15 days' written notice.

Key numbers

Metric	Latest	Change	Source
ATM prospectus cap	up to $5.32 million		SEC 8-K
Commission	3.0%		Equity Distribution Agreement
Specified expenses reimbursement	up to $40,000		SEC 8-K
Counsel fees and incidental expenses	up to $3,000 quarterly		SEC 8-K
Mutual termination notice	15 days		Equity Distribution Agreement

Read more: T Stamp (IDAI) stock analysis and investment case

Why it matters

OptimistFi's case is that IDAI only works if T Stamp turns identity software into repeatable revenue before dilution eats the upside. This filing weakens that case by adding another equity funding channel. It does not show new operating revenue. The reimbursable expense cap is about 0.75% of the ATM cap, so the fixed costs are small next to the possible share issuance.

T Stamp says no assurance can be given on price, amount or timing, and it does not have to sell any shares. Future disclosure of sales would show whether T Stamp uses the facility. For now, the filing is a financing option, not proof that the business has cleared its revenue hurdle.

Browse: stock research on every company OptimistFi covers

What's next

Any sales will depend on T Stamp's future instructions and the agreement's terms. The company and Maxim can also end the arrangement on 15 days' written notice. If T Stamp later discloses sales under the facility, investors can see how much of the cap is used and how much dilution follows. If no sales are disclosed, the filing remains a financing option rather than evidence of operating progress.

More from OptimistFi